These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19581612)

  • 41. [Methods of evaluating drug therapy, particularly in cardiovascular diseases].
    Lövy O; Toman J
    Cesk Zdrav; 1984 Sep; 32(8-9):361-5. PubMed ID: 6509673
    [No Abstract]   [Full Text] [Related]  

  • 42. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of cardiovascular drugs prescribed for an elderly Swedish population.
    Ding M; Wang R; Johnell K; Qiu C
    Int J Cardiol; 2014 Dec; 177(3):1091-4. PubMed ID: 25449520
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug costs may top $750 PMPY by 2004.
    Capitation Rates Data; 2000 Oct; 5(10):115-8. PubMed ID: 11147537
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of therapeutic reference pricing on innovation in cardiovascular medicine.
    Sheridan D; Attridge J
    Pharmacoeconomics; 2006 Dec; 24 Suppl 2():35-54. PubMed ID: 23389487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacological need and pharmacological economy in cardiology].
    Garattini S
    G Ital Cardiol; 1997 Dec; 27(12):1315-8. PubMed ID: 9470067
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
    Czernichow S; Knol MJ; Fezeu L; Grobbee DE
    Eur J Prev Cardiol; 2012 Jun; 19(3):484-9. PubMed ID: 21464100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Data watch. How employers are tackling Rx costs.
    Bus Health; 1999 Jul; 17(7):48. PubMed ID: 10539172
    [No Abstract]   [Full Text] [Related]  

  • 50. What future does the pharmaceutical industry have in the cardiovascular world?
    Braunwald E
    Eur Heart J; 2013 Apr; 34(13):943-4. PubMed ID: 23546415
    [No Abstract]   [Full Text] [Related]  

  • 51. Coverage of drug costs: reference-based pricing.
    McGregor M
    Can J Cardiol; 1998 May; 14(5):666-8. PubMed ID: 9627520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of medicines in Canada.
    Han D; Wang EC
    Can J Clin Pharmacol; 2005; 12(1):e10-21. PubMed ID: 16055940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managed care outlook. What's behind increases in pharmaceutical spending?
    Manag Care; 1998 Feb; 7(2):70. PubMed ID: 10178891
    [No Abstract]   [Full Text] [Related]  

  • 54. Study shows increases in drug costs may be justified by improvements in outcomes.
    Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
    [No Abstract]   [Full Text] [Related]  

  • 55. Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: a population-based study, 2004-2008.
    Sabo A; Tomić Z; Stilinović N; Milijašević B; Mikov M; Vukmirović S; Horvat O
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):45-9. PubMed ID: 20938914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Costs and Caution Yield Slow Start for New Heart Drugs.
    Kuehn BM
    Circulation; 2018 Jan; 137(2):197-199. PubMed ID: 29311350
    [No Abstract]   [Full Text] [Related]  

  • 57. The cost-effectiveness of cardiovascular medicine in Greece: brief notes.
    Vardas PE
    Hellenic J Cardiol; 2012; 53(4):333-4. PubMed ID: 22796825
    [No Abstract]   [Full Text] [Related]  

  • 58. Do higher drug costs lead to better health?
    Mintzes B; Lexchin J
    Can J Clin Pharmacol; 2005; 12(1):e22-7. PubMed ID: 16055941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. National trends in prescription drug expenditures and projections for 2019.
    Schumock GT; Stubbings J; Hoffman JM; Wiest MD; Suda KJ; Rim MH; Tadrous M; Tichy EM; Cuellar S; Clark JS; Matusiak LM; Hunkler RJ; Vermeulen LC
    Am J Health Syst Pharm; 2019 Jul; 76(15):1105-1121. PubMed ID: 31199861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.